The Japan Diabetes Society (JDS) decided to use National Glycohemoglobin Standardization Program (NGSP) values, as well as JDS HbA1c values, in clinical practice for international clinical harmonization of HbA1c [1] . Accordingly, NGSP certification of Japanese manufacturers of diagnostic reagents and instruments related to HbA1c was initiated in February, 2012, through NGSP Network Laboratory, the Asian Secondary Reference Laboratory (ASRL) #1 [2] . As a result, 21 routine methods were certified in 2012 and 42 in 2013. Moreover, traceability to the NGSP reference system can now be endorsed by both manufacturer certification and the College of American Pathologists (CAP) survey. The CAP survey is useful for monitoring between-certification proficiency of certified methods. However, only a few manufacturers participate in the CAP survey in Japan. Thus, proficiency testing (PT) similar to the CAP survey targeting NGSP-certified manufacturers and laboratories in Asia has been proposed and executed by ASRL #1 in collaboration with the Japan Reference Measurement Institute (JRMI). The committee for the PT was organized by the Reference Material Institute for Clinical Chemistry Standards (ReCCS) in collaboration with JRMI.
Five PT samples were prepared: PT samples 1, 2, 4, and 5 were single-donor whole-blood aliquots, and PT sample 3 was a mixture of PT samples 1 and 4, with plasma replaced by physiological saline solution. PT samples were drawn from two Japanese individuals in Japan and two diabetes patients in USA with informed consent and with the approval of the Ethics Committee of ReCCS. PT sample 3 for A1c GEAR in Table 1 shows abnormally high HbA1c values because only whole blood can be applied to A1c GEAR; therefore, in the mean value obtained by immunoassay, the A1c GEAR result of this sample was excluded in Table 2 .
ReCCS prepared and shipped the test samples. PT samples were stored in a refrigerator (2-8°C) until shipment, and at each laboratory, they were removed from the container immediately on receipt and then stored in a refrigerator (2-8°C) until use. Analyses were completed within two days of receipt when less than 14 days passed after each sample collection.
The participated measurement systems were NGSP certified (according to manufacturer's methods and laboratory certification) by ASRL #1, SRL #8, and SRL #9. Each PT sample was measured in duplicate. Measured HbA1c values were reported to 2 decimal places. Mean values (calculated to 3 decimal places) of the duplicate values for each PT sample were reported as final values, which were compared with target values determined by ASRL #1. The obtained values were consistent with those of SRL #8 and SRL #9. An overall test of coincidence by 2 least squares linear regression lines was performed using Microsoft Office Excel 2007.
A total of 33 laboratories (29 Japanese and four overseas laboratories) participated in the PT. Among these facilities, 22 were certified by NGSP through ASRL #1, two through SRL #8, and nine through SRL #9. Furthermore, 17 participating laboratories used immunoassay, four used enzymatic assay, and 12 used HPLC. PT samples 4 and 5 yielded HbA1c values over 12 NGSP %, which exceeded measurement ranges for some measurement instruments; therefore, these values were excluded for those systems. Target values of PT samples 1, 2, 3, 4, and 5 were determined by ASRL #1 to be 4.86 NGSP%, 5.64 NGSP%, 8.00 NGSP%, 12.68 NGSP%, and 12.78 NGSP%, respectively. The comparison of values as measured by instruments and the NGSP/ASRL target values are shown in Table1.
The regression line comparing the relationship between total mean values and target values was Y (the total mean values) = 1.013 × (the target value)+0.141. That is, the total mean values were higher than the target values. Furthermore, the values of CV of PT samples 1 through 5 were 3.72%, 2.54%, 2.23%, 2.41%, and 2.71%, respectively. PT sample 3 (containing red cells and saline) did not show any difference compared with other hemolyzed blood samples. CV values were 2.51-4.51% by immunoassay, 1.05-2.53% by enzymatic assay, and 1.73-2.63% by HPLC (Table 2) .
Compatibility with JDS criteria (less than or equal to a relative bias of ± 5.0% by mean of duplicate measurement) was checked by comparing the measured values of test samples 1 through 3 for the certification of 5% to10.0% HbA1c. The results indicate that 26 out of 28 methods in test sample 1, 26 out of 28 in test sample 2, and 26 out of 27 in test sample 3 were compatible with JDS criteria [1] . Fig. 1 shows combination plots of bias data in this study and bias data from NGSP certification through ASRL #1 conducted during March and May, 2012. Bias plots of mean values versus target values of PT samples in this report are also shown for comparison, and they are in good agreement with each other.
The determined target values using the Central Primary Reference Laboratory reference panels (100 samples) correspond with measured values obtained by SRL #3 and SRL #9. In con- 
